Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreGet the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers
Learn MoreImproving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search JobsCardiovascular disease (CVD) is an important healthcare challenge for Malaysia in modern times as more and more citizens are being diagnosed with this disease at a younger age than before. This rising prevalence of CVD-related illness and death does not just impact patients and families but also puts an unsustainable economic burden on the nation.
In collaboration with cardiologists, endocrinologists, public health, family medicine and pharmacoeconomic experts, this white paper aims to provide insights into the current state of CVD in Malaysia. As the burden of CVD continues to escalate, there is a vital need for industry leaders and HCPs to co-create patient-centric solutions. This paper therefore identifies gaps and opportunities followed by a proposal of five main strategies to effectively tackle the disease burden.